FDA
- Stories
The FDA Shows Green Light To Johnson & Johnson As It Becomes The 3rd Vaccine To Get Emergency Use Approval
The FDA Shows Green Light To Johnson & Johnson As It Becomes The 3rd Vaccine To Get Emergency Use Approval…
Read More » - Stories
Moderna gets emergency use authorisation for its COVID-19 vaccine in US
Moderna has become the second company to get emergency use authorisation for its anti-coronavirus vaccine from the US Food and…
Read More » - Stories
Pfizer’s Covid- 19 Vaccine causes a severe reaction in Two US Health care worker’s; FDA issues guidelines for people with a history of reactions
The world heaved a huge sign of relief and watched in awe when Britain and the US both gave the…
Read More » - Stories
#Covid-19: FDA Approves Crisis Utilization Of The Neutralizer Mixed Drink Given To Trump To Treat COVID-19
#Covid-19: FDA Approves Crisis Utilization Of The Neutralizer Mixed Drink Given To Trump To Treat COVID-19 The US Food and…
Read More » - Stories
FDA allows emergency use of antibody drug Trump received
US health officials have agreed to allow emergency use of a second antibody drug to help the immune system fight…
Read More » - Stories
Pfizer seeking emergency use of its COVID-19 vaccine in US
Pfizer said Friday it is asking US regulators to allow emergency use of its COVID-19 vaccine, starting the clock on…
Read More » - Stories
Pfizer, BioNTech conclude Phase 3 study of COVID-19 vaccine candidate, say it’s 95% effective
Global drugmakers Pfizer and BioNTech said on Wednesday that their COVID-19 vaccine was found 95 per cent effective in the…
Read More » - Stories
Pfizer shares zoom 20 pc on vaccine report
Shares of Pfizer Limited zoomed nearly 20 per cent on Tuesday after Pfizer Inc and BioNTech SE said their vaccine…
Read More » - Stories
FDA Authorizes Use of Plasma From Recovered Patients to Treat COVID-19
President Donald Trump on Sunday announced emergency authorization to treat COVID-19 patients with convalescent plasma — a move he called…
Read More » - Health
Mammoth Biosciences’s CRISPR-based COVID-19 test receives NIH fundings through RADx program
CRISPR tech startup Mammoth Biosciences is among the companies that revealed backing from the National Institutes of Health (NIH) Rapid…
Read More »